Ah, To Be A Project Manager In 2016!

By Louis Garguilo, Chief Editor, Outsourced Pharma

This is the reality that 2016 has wrought: Big Pharma is continuing to organize for enhanced utilization of external partners and supply chains. More business models — biotechs, startups, virtuals – rely on outsourcing. CROs/CMOs are reacting to these client changes with their new service models, technologies and facilities, and M&As.

Add the fact of more but smaller projects at a quickened pace of delivery and turnover, and it all leads to, among other things, a weight and force landing on the backs of a particular set of individuals:

Ah, to be a project manager in the biopharma industry in 2016!